Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

5α reductase type 2 enzyme mutation and oxidative stress may increase androgenetic alopecia risk in Egyptians.

Early diagnosis and treatment of NCCAH can improve symptoms and fertility.

Women with hair loss have higher androgen levels, while men with early balding have altered androgen ratios.

Mutations in the androgen receptor gene cause different levels of androgen insensitivity, making it hard to create simple tests for the condition.

Women with androgenetic alopecia may have higher blood pressure levels.

People with hair loss have more androgen receptors and enzymes in certain follicles, with men and women showing different patterns.

A new gene, JMJD1C, may affect testosterone levels in men.

Finger length ratios are not linked to the number of specific gene repeats affecting testosterone sensitivity.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

SHBG binding properties are unchanged in male liver cirrhosis patients.

Red deer only have androgen receptors in neck hair cells for mane growth during breeding season.

Benign Prostatic Hyperplasia may be caused by changes in how the body processes male hormones.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

The T-zone on the face has more androgen receptors and produces more oil than the U-zone.

Inflammation around hair follicles may worsen hair loss; evaluating and treating it can improve transplant results.

Current research explores hair growth drugs, while future research aims for personalized treatments.

Glioblastoma cells can make androgens, which might help the tumor grow.

Sex steroids affect the MafB gene differently in male and female hamsters.

Gene mutations can cause problems in male genital development.

Many men with male pattern baldness have abnormal blood fat levels, which may raise their risk of heart disease.

Endocrine disruptors may cause early hair loss.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

PRGF treatment safely and effectively helps hair loss.

PRFM may help treat hair loss, especially in mild cases.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

Finasteride's effect on hair loss and prostate enlargement depends on its binding to an enzyme, with maximum impact at 0.2 mg dose.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

Women with AGA have higher lipid levels, increasing heart disease risk.

Dutasteride and finasteride affect different cell types differently.